scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.AMJCARD.2005.11.060 |
P698 | PubMed publication ID | 16635602 |
P50 | author | Francesco Versaci | Q46000244 |
Achille Gaspardone | Q90007264 | ||
Fabrizio Tomai | Q118957129 | ||
P2093 | author name string | Igino Proietti | |
Olga Skossyreva | |||
Gaetano Gioffrè | |||
Carlo Citone | |||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1311-1316 | |
P577 | publication date | 2006-03-20 | |
P1433 | published in | American Journal of Cardiology | Q2208417 |
P1476 | title | C-Reactive protein, clinical outcome, and restenosis rates after implantation of different drug-eluting stents. | |
P478 | volume | 97 |
Q58471428 | A transthoracic Doppler echocardiography study of C-reactive protein and coronary microcirculation in children after open heart surgery |
Q37362731 | Avoiding restenosis: is there a role for glucocorticoids in the drug-eluting stent era? |
Q39240862 | Interleukin-6, but not C-reactive protein, predicts the occurrence of cardiovascular events after drug-eluting stent for unstable angina |
Q88535298 | Novel Biomarkers for Coronary Restenosis Occurrence After Drug-Eluting Stent Implantation in Patients With Diabetes Having Stable Coronary Artery Disease |
Q51036735 | Percutaneous treatment of coronary bifurcations: lesion preparation before provisional bare metal stenting and subsequent immunosuppression with oral prednisone. The IMPRESS-Y study. |
Q37709401 | Predictive value of C-reactive protein after drug-eluting stent implantation |
Q28548500 | Prognostic Impact of 9-Month High-Sensitivity C-Reactive Protein Levels on Long-Term Clinical Outcomes and In-Stent Restenosis in Patients at 9 Months after Drug-Eluting Stent Implantation |
Q35954252 | Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation |
Q54655905 | Serum inflammatory and immune marker response after bare-metal or drug-eluting stent implantation following percutaneous coronary intervention. |
Q41909214 | Stent hypersensitivity and infection in sinus cavities |
Q84535196 | Synthetic peptide fragment (65-76) of monocyte chemotactic protein-1 (MCP-1) inhibits MCP-1 binding to heparin and possesses anti-inflammatory activity in stable angina patients after coronary stenting |
Q39050235 | The effects of bare metal versus drug-eluting stent implantation on circulating endothelial cells following percutaneous coronary intervention. |
Search more.